These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3260790)

  • 21. HIV experimental vaccines based on the iscom technology using envelope and GAG gene products.
    Akerblom L; Nara P; Dunlop N; Putney S; Morein B
    Biotechnol Ther; 1993; 4(3-4):145-61. PubMed ID: 8292967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization of macaques with soluble HIV type 1 and influenza virus envelope glycoproteins results in a similarly rapid contraction of peripheral B-cell responses after boosting.
    Sundling C; Martinez P; Soldemo M; Spångberg M; Bengtsson KL; Stertman L; Forsell MN; Karlsson Hedestam GB
    J Infect Dis; 2013 Feb; 207(3):426-31. PubMed ID: 23162135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. B cell epitope mapping of human immunodeficiency virus envelope glycoproteins with long (19- to 36-residue) synthetic peptides.
    Neurath AR; Strick N; Lee ES
    J Gen Virol; 1990 Jan; 71 ( Pt 1)():85-95. PubMed ID: 1689372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV gp120-specific cell-mediated immune responses in mice after oral immunization with recombinant Salmonella.
    Berggren RE; Wunderlich A; Ziegler E; Schleicher M; Duke RC; Looney D; Fang FC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):489-95. PubMed ID: 8548327
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibodies to human immunodeficiency virus in human sera induce cell-mediated lysis of human immunodeficiency virus-infected cells.
    Ojo-Amaize EA; Nishanian P; Keith DE; Houghton RL; Heitjan DF; Fahey JL; Giorgi JV
    J Immunol; 1987 Oct; 139(7):2458-63. PubMed ID: 2821115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic and mucosal immunity in rhesus macaques immunized with HIV-1 peptide and gp120 conjugated to Brucella abortus.
    Eller N; Golding H; Inoue S; Beining P; Inman J; Matthews N; Scott DE; Golding B
    J Med Primatol; 2004 Aug; 33(4):167-74. PubMed ID: 15271066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sensitivity and specificity of anti-HIV ELISA employing recombinant (p24, p66, gp120) and synthetic (gp41) viral antigenic peptides.
    Filice G; Soldini L; Orsolini P; Razzini E; Gulminetti R; Campisi D; Chiapparoli L; Cattaneo E; Achilli G
    Microbiologica; 1991 Jul; 14(3):185-94. PubMed ID: 1717811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.
    Schrier RD; Gnann JW; Langlois AJ; Shriver K; Nelson JA; Oldstone MB
    J Virol; 1988 Aug; 62(8):2531-6. PubMed ID: 3260630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
    Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
    Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with gp120-depleted HIV-1 plus immunostimulatory CpG oligodeoxynucleotides in incomplete Freund's adjuvant stimulates cellular and humoral immunity in rhesus macaques.
    Silvera P; Savary JR; Livingston V; White J; Manson KH; Wyand MH; Salk PL; Moss RB; Lewis MG
    Vaccine; 2004 Dec; 23(6):827-39. PubMed ID: 15542208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of combination DNA/replication-competent Ad-SIV recombinant immunization regimens in rhesus macaques.
    Malkevitch N; Rohne D; Pinczewski J; Aldrich K; Kalyanaraman VS; Letvin NL; Robert-Guroff M
    AIDS Res Hum Retroviruses; 2004 Feb; 20(2):235-44. PubMed ID: 15018712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-directed primary in vitro immunization: production of HIV-1 neutralizing human monoclonal antibodies from lymphocytes obtained from seronegative donors.
    Chin LT; Hinkula J; Levi M; Ohlin M; Wahren B; Borrebaeck CA
    Immunology; 1994 Mar; 81(3):428-34. PubMed ID: 7515847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of human monoclonal antibodies to human immunodeficiency virus.
    Gorny MK; Gianakakos V; Sharpe S; Zolla-Pazner S
    Proc Natl Acad Sci U S A; 1989 Mar; 86(5):1624-8. PubMed ID: 2922401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocyte and iscom enhancement of cell-mediated response to cytomegalovirus.
    Wahren B; Nordlund S; Akesson A; Sundqvist VA; Morein B
    Med Microbiol Immunol; 1987; 176(1):13-9. PubMed ID: 3029554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Karpas HIV cell test to detect antibodies to HIV-2.
    Karpas A; Hayhoe FG; Hill F; Anderson M; Tenant-Flower M; Howard L; Oates JK
    Lancet; 1987 Jul; 2(8551):132-3. PubMed ID: 2439855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A sensitive radioimmunoprecipitation assay for human immunodeficiency virus (HIV).
    Pinter A; Honnen WJ
    J Immunol Methods; 1988 Sep; 112(2):235-41. PubMed ID: 3418129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous in vitro production of virus-specific antibody by lymphocytes from HIV-infected subjects.
    Amadori A; De Rossi A; Faulkner-Valle GP; Chieco-Bianchi L
    Clin Immunol Immunopathol; 1988 Mar; 46(3):342-51. PubMed ID: 3257430
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anatomic segmentation of the intestinal immune response in nonhuman primates: differential distribution of B cells after oral and rectal immunizations to sites defined by their source of vascularization.
    Eriksson K; Quiding-Järbrink M; Osek J; Nordström I; Hjulström M; Holmgren J; Czerkinsky C
    Infect Immun; 1999 Nov; 67(11):6210-2. PubMed ID: 10531293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An accurate confirmation of human immunodeficiency virus type 1 (HIV-1) and 2 (HIV-2) infections with a dot blot assay using recombinant p24, gp41, gp120 and gp36 antigens.
    Int J Med Sci; 2008; 5(6):377. PubMed ID: 19156933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.